{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:30:32Z","timestamp":1762428632978,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04554-w","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:25:53Z","timestamp":1762428353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-7974 as a potential biomarker for lupus nephritis and its involvement in disease progression"],"prefix":"10.1186","volume":"26","author":[{"given":"Rongzheng","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"4554_CR1","doi-asserted-by":"publisher","first-page":"1200732","DOI":"10.3389\/fimmu.2023.1200732","volume":"14","author":"SCW Chan","year":"2023","unstructured":"Chan SCW, Wang YF, Yap DYH, Chan TM, Lau YL, Lee PPW, Lai WM, Ying SKY, Tse NKC, Leung AMH, Mok CC, Lee KL, Li TWL, Tsang HHL, Yeung WWY, Ho CTK, Wong RWS, Yang W, Lau CS, Li PH. Risk and factors associated with disease manifestations in systemic lupus erythematosus - lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients. Front Immunol. 2023;14:1200732. https:\/\/doi.org\/10.3389\/fimmu.2023.1200732.","journal-title":"Front Immunol"},{"key":"4554_CR2","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.3390\/ijms22073766","volume":"22","author":"B Obri\u0219c\u0103","year":"2021","unstructured":"Obri\u0219c\u0103 B, Sorohan B, Tu\u021b\u0103 L, Ismail G. Advances in lupus nephritis pathogenesis: from bench to bedside. Int J Mol Sci. 2021;22:3766. https:\/\/doi.org\/10.3390\/ijms22073766.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"4554_CR3","doi-asserted-by":"publisher","first-page":"8981","DOI":"10.3390\/ijms25168981","volume":"25","author":"A Roveta","year":"2024","unstructured":"Roveta A, Parodi EL, Brezzi B, Tunesi F, Zanetti V, Merlotti G, Francese A, Maconi AG, Quaglia M. Lupus nephritis from pathogenesis to new therapies: an update. Int J Mol Sci. 2024;25(16):8981. https:\/\/doi.org\/10.3390\/ijms25168981.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"4554_CR4","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.3390\/ijms23137167","volume":"23","author":"PTB Ho","year":"2022","unstructured":"Ho PTB, Clark IM, Le LTT. MicroRNA-Based diagnosis and therapy. Int J Mol Sci. 2022;23(13):7167. https:\/\/doi.org\/10.3390\/ijms23137167.","journal-title":"Int J Mol Sci"},{"key":"4554_CR5","doi-asserted-by":"publisher","first-page":"4126106","DOI":"10.1155\/2018\/4126106","volume":"2018","author":"M Honarpisheh","year":"2018","unstructured":"Honarpisheh M, K\u00f6hler P, von Rauchhaupt E, Lech M. The involvement of MicroRNAs in modulation of innate and adaptive immunity in systemic lupus erythematosus and lupus nephritis. J Immunol Res. 2018;2018:4126106. https:\/\/doi.org\/10.1155\/2018\/4126106.","journal-title":"J Immunol Res"},{"key":"4554_CR6","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3389\/fimmu.2019.02229","volume":"10","author":"Y Tu","year":"2019","unstructured":"Tu Y, Guo R, Li J, Wang S, Leng L, Deng J, Bucala R, Lu L. MiRNA regulation of MIF in SLE and Attenuation of murine lupus nephritis with miR-654. Front Immunol. 2019;10:2229. https:\/\/doi.org\/10.3389\/fimmu.2019.02229.","journal-title":"Front Immunol"},{"issue":"9","key":"4554_CR7","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41374-022-00788-6","volume":"102","author":"X Miao","year":"2022","unstructured":"Miao X, Tian Y, Wu L, Zhao H, Liu J, Gao F, Zhang W, Liu Q, Guo H, Yang L, Yang R, Feng X, Liu S. CircRTN4 aggravates mesangial cell dysfunction by activating the miR-513a-5p\/FN axis in lupus nephritis. Lab Invest. 2022;102(9):966\u201378. https:\/\/doi.org\/10.1038\/s41374-022-00788-6.","journal-title":"Lab Invest"},{"key":"4554_CR8","doi-asserted-by":"publisher","first-page":"1326836","DOI":"10.3389\/fimmu.2023.1326836","volume":"14","author":"F Chen","year":"2023","unstructured":"Chen F, Shi B, Liu W, Gong J, Gao J, Sun Y, Yang P. Circulating Exosomal MicroRNAs as biomarkers of lupus nephritis. Front Immunol. 2023;14:1326836. https:\/\/doi.org\/10.3389\/fimmu.2023.1326836.","journal-title":"Front Immunol"},{"key":"4554_CR9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al. 2019 European league against Rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214819.","journal-title":"Ann Rheum Dis"},{"issue":"105","key":"4554_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","volume":"2024","author":"Kidney Disease: Improving Global Outcomes Lupus Nephritis Work G. KDIGO","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes Lupus Nephritis Work G. KDIGO. Clinical practice guideline for the management of LUPUS NEPHRITIS. Kidney Int. 2024;2024(105):S1\u201369. https:\/\/doi.org\/10.1016\/j.kint.2023.09.002.","journal-title":"Kidney Int"},{"issue":"1","key":"4554_CR11","doi-asserted-by":"publisher","first-page":"2423758","DOI":"10.1080\/08916934.2024.2423758","volume":"57","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li P, Wang L, Jiang L, Li Z, Mei Y, Deng W. iTreg cells-secreted IL10 alleviates lupus nephritis through inactivating LncRNA HAR1A transcription to suppress SMARCD1-mediated iNOS activation. Autoimmunity. 2024;57(1):2423758. https:\/\/doi.org\/10.1080\/08916934.2024.2423758.","journal-title":"Autoimmunity"},{"key":"4554_CR12","doi-asserted-by":"publisher","first-page":"102438","DOI":"10.1016\/j.jaut.2020.102438","volume":"109","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wu H, Zhao M, Chang C, Lu Q. Clinical significance of MiRNAs in autoimmunity. J Autoimmun. 2020;109:102438. https:\/\/doi.org\/10.1016\/j.jaut.2020.102438.","journal-title":"J Autoimmun"},{"issue":"2","key":"4554_CR13","doi-asserted-by":"publisher","first-page":"101741","DOI":"10.1016\/j.beem.2023.101741","volume":"37","author":"R Mart\u00ednez-Hern\u00e1ndez","year":"2023","unstructured":"Mart\u00ednez-Hern\u00e1ndez R, Marazuela M. MicroRNAs in autoimmune thyroid diseases and their role as biomarkers. Best Pract Res Clin Endocrinol Metab. 2023;37(2):101741. https:\/\/doi.org\/10.1016\/j.beem.2023.101741.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"4554_CR14","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.2174\/0118715303250919231010073608","volume":"24","author":"M Abdelsalam","year":"2024","unstructured":"Abdelsalam M, Zaki MES, Abo El-Kheir NY, Salama MF, Osman AOBS. Study of MicroRNA-124 in patients with lupus nephritis. Endocr Metab Immune Disord Drug Targets. 2024;24(10):1180\u20135. https:\/\/doi.org\/10.2174\/0118715303250919231010073608.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"6","key":"4554_CR15","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s10067-025-07447-3","volume":"44","author":"F Chen","year":"2025","unstructured":"Chen F, Gao J, Shi B, Liu W, Gong J, Khan A, Sun Y, Yang P, Li Z. Identification of serum Exosomal MiRNA biomarkers in patients with lupus nephritis. Clin Rheumatol. 2025;44(6):2299\u2013310. https:\/\/doi.org\/10.1007\/s10067-025-07447-3.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"4554_CR16","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.3390\/ijms22073766","volume":"22","author":"B Obri\u0219c\u0103","year":"2021","unstructured":"Obri\u0219c\u0103 B, Sorohan B, Tu\u021b\u0103 L, Ismail G. Advances in lupus nephritis pathogenesis: from bench to bedside. Int J Mol Sci. 2021;22(7):3766. https:\/\/doi.org\/10.3390\/ijms22073766.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4554_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000045663","volume":"85","author":"CY Tsai","year":"2000","unstructured":"Tsai CY, Wu TH, Yu CL, Lu JY, Tsai YY. Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron. 2000;85(3):207\u201314. https:\/\/doi.org\/10.1159\/000045663.","journal-title":"Nephron"},{"issue":"1","key":"4554_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/rheumatology\/keaa300","volume":"60","author":"T Katsuyama","year":"2021","unstructured":"Katsuyama T, Li H, Krishfield SM, Kyttaris VC, Moulton VR. Splicing factor SRSF1 limits IFN-\u03b3 production via RhoH and ameliorates experimental nephritis. Rheumatology (Oxford). 2021;60(1):420\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keaa300.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"4554_CR19","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.3892\/mmr.2016.5939","volume":"14","author":"F Yao","year":"2016","unstructured":"Yao F, Sun L, Fang W, Wang H, Yao D, Cui R, Xu J, Wang L, Wang X. Hsa-miR-371-5p inhibits human mesangial cell proliferation and promotes apoptosis in lupus nephritis by directly targeting hypoxia-inducible factor 1\u03b1. Mol Med Rep. 2016;14(6):5693\u20138. https:\/\/doi.org\/10.3892\/mmr.2016.5939.","journal-title":"Mol Med Rep"},{"issue":"1","key":"4554_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.17116\/patol20258701160","volume":"87","author":"EA Prosekina","year":"2025","unstructured":"Prosekina EA, Shapkina VA, Karpov AE, Fedorutseva EY, Artemyeva AS. Belok DDAH1: biologicheskie funktsii, rol\u2019 v Protsessakh Kantserogeneza [DDAH1 protein: biological functions, role in carcinogenesis processes]. Arkh Patol. 2025;87(1):60\u20137. https:\/\/doi.org\/10.17116\/patol20258701160. Russian.","journal-title":"Arkh Patol"},{"issue":"8","key":"4554_CR21","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1016\/j.apsb.2023.05.020","volume":"13","author":"X Shen","year":"2023","unstructured":"Shen X, Luo K, Yuan J, Gao J, Cui B, Yu Z, Lu Z. Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: involvement of reduced S100A11 expression. Acta Pharm Sin B. 2023;13(8):3352\u201364. https:\/\/doi.org\/10.1016\/j.apsb.2023.05.020.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"4554_CR22","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/antiox11050880","volume":"11","author":"X Shen","year":"2022","unstructured":"Shen X, Ishaq SM, Wang Q, Yuan J, Gao J, Lu Z. DDAH1 protects against Acetaminophen-Induced liver hepatoxicity in mice. Antioxid (Basel). 2022;11(5):880. https:\/\/doi.org\/10.3390\/antiox11050880.","journal-title":"Antioxid (Basel)"},{"issue":"9","key":"4554_CR23","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3390\/antiox12091754","volume":"12","author":"F Feng","year":"2023","unstructured":"Feng F, Cui B, Fang L, Lan T, Luo K, Xu X, Lu Z. DDAH1 protects against Cardiotoxin-Induced muscle injury and regeneration. Antioxid (Basel). 2023;12(9):1754. https:\/\/doi.org\/10.3390\/antiox12091754.","journal-title":"Antioxid (Basel)"},{"issue":"6","key":"4554_CR24","doi-asserted-by":"publisher","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","volume":"293","author":"F Palm","year":"2007","unstructured":"Palm F, Onozato ML, Luo Z, Wilcox CS. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol. 2007;293(6):H3227\u201345. https:\/\/doi.org\/10.1152\/ajpheart.00998.2007.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"4554_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2217\/pme-2016-0065","volume":"14","author":"S Wu","year":"2017","unstructured":"Wu S, Wang J, Li F. Dysregulation of miRNA-146a contributes to the development of lupus nephritis via targeting of TRAF6. Per Med. 2017;14(2):131\u20139. https:\/\/doi.org\/10.2217\/pme-2016-0065.","journal-title":"Per Med"},{"issue":"1","key":"4554_CR26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12951-024-03063-6","volume":"22","author":"J Ji","year":"2024","unstructured":"Ji J, He Q, Xia Y, Sha X, Liang Q, Xu Y, Chen P, Dong C, Zhao R, Yang J, Guo H, Wang Y, Cao H, Li J, Yang M, Gu Z. Circulating plasma derived exosomes from systemic lupus erythematosus aggravate lupus nephritis through miR-122-5p\/FOXO3-mediated macrophage activation. J Nanobiotechnol. 2024;22(1):779. https:\/\/doi.org\/10.1186\/s12951-024-03063-6.","journal-title":"J Nanobiotechnol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04554-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04554-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04554-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:25:54Z","timestamp":1762428354000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04554-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4554"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04554-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the Helsinki Declaration and has been approved by the Medical Ethics Committee of Kidney Research Institute, West China Hospital of Sichuan University. Each participant signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"621"}}